Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Decision Impact Clinical Utility Trial of KidneyIntelX in Patients With Type 2 Diabetes and Existing Chronic Kidney Disease

NCT05198284 is registered in ClinicalTrials.gov with Renalytix AI, Inc. as lead sponsor.

NCT NCT05198284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05198284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Decision Impact Clinical Utility Trial of KidneyIntelX in Patients With Type 2 Diabetes and Existing Chronic Kidney Disease
Lead sponsor
Renalytix AI, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
November 1, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 1, chronic kidney disease stage 2, chronic kidney disease stage 3, chronic kidney diseases, diabetic kidney disease